Thursday, February 08, 2024

Real Driving Forces Behind the COVID Waves

“Stay 6 feet apart.” This unforgettable slogan was one of the first recommendations implemented when the world announced the first COVID-19 wave.

As the mysterious virus appeared and quickly spread throughout the world, countries sealed their borders, schools closed, travel was restricted, and people started working remotely. We were told to wear masks, social distance to “flatten the curve,” and get vaccines promoted as being “safe and effective.”

The COVID-19 waves have come and gone approximately seven to eight times during the last three years until May 2023, when the public health emergency and the national state of emergency for COVID-19 were officially declared over. What we experienced during that time will be etched in our minds forever.

Among a number of public health measurements taken during the COVID-19 pandemic, which factors affected the COVID waves? Social distancing? Masks? Vaccines? Or something else?

Researchers have analyzed these factors to determine their effectiveness.

Impact of Nonpharmaceutical Interventions

Many people attributed a reduction in COVID-19 cases to nonpharmaceutical health policies.

These included travel restrictions, stay-at-home orders, mask mandates, school closures, and social distancing measures. Since they have nothing to do with pharmaceuticals, they are classified as nonpharmaceutical interventions (NPIs).

More Than 400 Studies on the Failure of Compulsory Covid Interventions

However, a number of studies disagree and couldn’t find clear evidence that these interventions contributed to the decline in each COVID-19 wave.

For example, in terms of mortality, fatal cases were declining before the full United Kingdom lockdown on March 24, 2020.

A systematic review of 32 studies conducted in Europe and the United States concluded that lockdowns during the spring of 2020 had no substantial effect on reducing COVID-19 mortality.

A study that analyzed data across 169 countries covering 98 percent of the world population from Our World in Data between July 1, 2020, and Sept. 1, 2021, also did “not find substantial COVID-19-related fatality-reducing effects of the ten NPIs under investigation.”

A Nature study found no evidence that Japanese school closures significantly reduced the number of COVID-19 cases in the spring of 2020.

A randomized controlled study in Denmark indicated that mask use did not significantly reduce the infection rate compared to the control.

A newly published 2024 study analyzing COVID-19 data in six European countries (Ireland, the UK, Denmark, Sweden, Norway, and Finland) found no clear evidence indicating that NPIs effectively altered the course of the pandemic in these countries, despite common misconceptions about them.

Impact of COVID-19 Vaccine

Many have been forced to comply with overwhelming vaccine mandates, and the impact of vaccination on the pandemic has been extensively researched.

Vaccination recommendations started for people at high risk and now include everyone, even children. Initially, the expectation was to stop the virus from spreading. Later, the authorities admitted to the public that it was still possible to get COVID-19 after vaccination. We were later told it was important for reducing hospitalization rates.

Despite early promising results from clinical trials indicating significant effectiveness, it’s essential to consider that these findings were based on a relatively small number of COVID-19 cases in the vaccine trials.

For instance, the Pfizer/BioNTech trial had 43,548 participants, but only 170 confirmed symptomatic COVID-19 cases were identified across both the vaccinated and placebo groups. Although the relative risk reduction was reported as 95 percent, this was calculated from a modest sample size exerting little impact on the whole patient population, raising major questions about the reliability of the conclusions.

Countries such as Israel and the UK were leaders in rolling out vaccine campaigns during the pandemic. Yet the same nations have frequently faced new waves of the virus, often driven by emerging variants.

The previously mentioned study on six European countries concluded that despite initial high hopes, there was no clear evidence that the vaccine altered the course of the pandemic.

Impact of Seasonality

A 2021 Nature study shows that higher temperatures and higher relative humidity have consistently adversely impacted COVID-19 transmission across large geographic areas.
The European six-country study, while dismissing the role of NPIs and the vaccine in the COVID waves, concluded that the patterns of COVID-19 cases, hospital admissions, and the number of people in intensive care units were surprisingly consistent, forming a visible seasonal pattern.

SARS-CoV-2 has been shown to behave like other respiratory viruses—peaking in mid-winter and having a very low incidence during the summer.

A study on the survival of SARS-CoV-2 on surfaces found that the virus survives better in colder and drier environments.
Airborne transmission plays a significant role in spreading SARS-CoV-2. In winter, when the air is usually drier and colder, the virus is more likely to survive and spread easier.

The survival of other coronaviruses also depends on temperature and humidity, showing a clear seasonal pattern.
While seasonal patterns are a driving force behind the COVID waves, they are just one piece of the puzzle and not the entire picture.

Another Surprising Factor

There have been many unknowns with this microscopic virus that remain a mystery.

A breakthrough study in Japan published in Nature revealed an unexpected finding about the COVID-19 pandemic: how people’s changing behaviors, like isolation, might have influenced the virus’s evolution.

The researchers used detailed clinical data and complex mathematical models to understand the viral behavior during the past four years of the COVID-19 pandemic.

It was found that as the virus mutated into the Delta variant, the newer strains displayed higher and earlier peaks in the viral load within the body. However, the infection duration was relatively shorter.

This suggests that the virus mutates to become more transmissible, which counteracts the measures people take, such as self-isolation.

Researchers discovered that the virus transitioned from having a shorter incubation period to being more infectious without showing symptoms. A typical example of this is the Omicron variant.

This is the virus’s way of adapting to human behavior; it is intelligent and appears to know how to outsmart human intervention.

It’s not surprising that even the most intelligent scientists and virologists cannot predict mutations, as we have seen with recent strains like HV.1 and JN.1.

Unfortunately, this has resulted in a challenging battle between viruses and human intervention, and the variants’ microscopic tricks appear to be far superior.

Human Behavior Matters

There are other factors related to human behavior that are often ignored yet may be fundamental to driving COVID-19 waves.

In modern health care, Western medicine often fails to address the human soul, including a decline in moral values and behavior, which is linked to the root causes of disease.

Intriguingly, not everyone succumbs to viruses, even during a pandemic. This fact has been evident since the 1918 Spanish flu outbreak and has been further supported by recent COVID-19 human challenge studies. Many participants who were exposed to the virus remained infection-free.

This phenomenon points to the extraordinary capabilities of our God-given natural immunity. The real frontline where the battles between viruses and humans take place is at a microscopic level—our natural defense system, including mucosal epithelial cells on the surface of our nose, lungs, and gut.

A remarkable link exists between our thoughts, moral values and behaviors, and our body’s ability to fight viruses on this battlefield.

It’s not only about nutrition and exercise; our mental state also plays a crucial role. Science has shown that emotions such as stress, anxiety, and fear can impact our biochemistry.

Furthermore, our body, mind, and spirit interplay with each other. Positivity and purposeful living can actually boost our immune response.

A study reveals that striving for compassionate, noble goals can supercharge our body’s virus-fighting abilities. Honesty isn’t just a virtue, it strengthens our immunity by lowering stress hormones.

Embracing a positive, purpose-driven life can not only fill us with joy but can also arm us against illness. Traditional wisdom meets modern science—kindness, altruism, and calmness aren’t just good for the soul; they’re secret weapons for staying healthy.

A pivotal driving force for the virus waves may not be external but something within ourselves. In other words, our behaviors and values may have contributed to the spread of the virus.




Wednesday, February 07, 2024

VAERS Data Reveals 223-Fold Increase in Myocarditis Reports Post-COVID-19 Vaccination

In the wake of the widespread distribution of COVID-19 vaccines, including Pfizer-BioNTech, Moderna and Janssen across the United States, a surge in adverse event reports was documented through the Vaccine Adverse Events Reports System (VAERS).

VAERS tracks vaccine side effects by allowing patients and healthcare professionals to report any unexpected reactions, helping authorities at the CDC and FDA to scrutinize and monitor vaccine safety. Concerns over safety issues with COVID-19 vaccination came as early as the beginning of 2021. Loss of medical licensure threatened doctors from voicing dissenting opinions. Medical professionals or news media who questioned short-term, or long-term safety with the novel vaccines, and strayed from the official public health messaging, were often censored—including this news media.

An analysis was recently published in Sage Journals, titled “Determinants of COVID-19 Vaccine-induced Myocarditis”. Myocarditis is inflammation of the heart muscle, often caused by viral infections or other immune-related conditions, and it can affect the heart's ability to pump blood effectively.

The creators of the investigation aimed to delve into VAERS data, specifically focusing on myocarditis cases, and explore the potential correlation between COVID-19 vaccines and the occurrence of myocarditis.

Utilizing statistical methods, the study assessed the frequency of myocarditis reports with respect to sex, age, and dose number, comparing them with historical values and vaccine administration data from the Our World in Data database.

The researchers uncovered troubling indications in the data. According to their analysis, myocarditis reports in VAERS following COVID-19 injection in 2021 were 223 times higher than the average of all vaccines in the past 30 years. This marked a 2500% increase in reports, with youths and males being most affected. Emergency care and hospitalization were required in 76% of cases, and 3% resulted in death. Myocarditis was more likely after the second dose, and individuals under 30 were at a higher risk.

They concluded that “COVID-19 vaccination is strongly associated with a serious adverse safety signal of myocarditis, particularly in children and young adults resulting in hospitalization and death. Further investigation into the underlying mechanisms of COVID-19 vaccine-induced myocarditis is imperative to create effective mitigation strategies and ensure the safety of COVID-19 vaccination programs across populations.”

Myocarditis and Vaccine-induced Myocarditis

Prior to the pandemic, four per million children were affected annually in the U.S., and it has been reported that 0.05% of all pediatric hospitalizations are attributed to myocarditis. This condition, more frequently identified in young males, has historical associations with various vaccines, including influenza and smallpox.

Myocarditis can present with symptoms such as chest pain, heart failure, or sudden death, posing a significant risk - especially among the young - making it the third leading cause of sudden cardiac death in children and young adults. In VAERS, myocarditis qualifies as a Serious Adverse Event (SAE).

The authors acknowledged that there were cases of myocarditis from SARS-CoV-2 infection before the rollout of vaccines. During severe COVID-19 illness, studies noted heart issues using certain codes. However, many reports didn't thoroughly check symptoms or use detailed diagnostic procedures like ECG or MRI: meaning that important diagnostic details associated with heart problems in COVID-19 might be missed in these studies.

Regarding COVID-19 vaccine-induced myocarditis, the authors wrote: “The prevalence of myocarditis reports in the VAERS system was significantly higher in the context of dose 2, males, and individuals under 30 years of age…Dose 2 was generally administered 3 weeks following the first dose – assuming the individual survives dose 1 without any major complications, including death. Figure 4 reveals five times more reports of myocarditis for dose 2 in 15-year-old males and regardless of age, myocarditis cases were more frequent following dose 2.”

The observation suggests a dose-response relationship, indicating potential cumulative and more damaging effects with each additional dose. “In such cases, it is possible that myocarditis was subclinical after dose 1 and became symptomatic after dose 2. We found 70% of all reports of myocarditis were filed within 7 days and 43% were made within 48 hours. Following dose 2, 77% of reports were filed within 7 days and 48% within 48 hours, thus providing more evidence of clinical concern and a temporal relationship with the injections.”

If signs of myocarditis are present after the first dose, the vaccinations should end there, and clinical monitoring should begin. “Because the duration of action of genetic material coding for spike protein is unknown, long-term follow-up with cardiology consultation may be advised in cases with possible repeat imaging and biomarkers.”

Why the Young and Athletic Might Be at Risk

Based on numerous autopsy studies involving suspected vaccine-induced myocarditis deaths, a theory has been formed that may explain why young males and athletes are particularly vulnerable.

Worldwide expert in both Endocrinology and Sports Medicine fields, Dr. Flavio A. Cadegiani, holds a unique endocrinological perspective to Physical Activity. In his Op-ed published by TrialSite News, Cadegiani examined multiple studies that provided evidence for a converging cause: that catecholamines, mostly represented by noradrenaline and adrenaline, are the “key triggers” of myocarditis and sudden deaths caused by COVID-19 mRNA vaccines.

This is more simply explained as an adrenaline surge feedback loop. With young males and athletes having the highest amount of catecholamines in their system, it’s likely the reason why this group experiences an overload after vaccination. This theory corroborates with the determination of Connecticut’s Medical Examiner who published a case-study on his autopsies of two teen boys who died in their sleep within days of COVID-19 vaccination.

Estimating the Bigger Picture

The article shared some disheartening information regarding “the spontaneous reporting nature of VAERS,” implying that the reported cases are likely not rare, but rather represent a fraction of the total occurrences. Acknowledging the significant under-reporting issue with VAERS, the study cautions against using it alone to estimate population incidence. With 3,078 reported myocarditis cases by August 11, 2023, and considering an under-reporting factor of 31, the study estimates the actual number of myocarditis cases in the United States to be around 95,418. If considering the under-reporting factor for the Foreign VAERS data-inclusive, this estimate becomes 564,696 since 83% of myocarditis reports are found in the Foreign VAERS data set.


AstraZeneca is facing tens of millions of pounds in compensation claims from 35 alleged victims of the Covid jab in High Court legal battle

The pharmaceutical giant, which developed its jab in partnership with the University of Oxford, is set to face a High Court battle over claims the vaccine is 'defective'.

It has been linked to a newly identified condition called Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) which causes blood clots.

At least 81 people have died due to complications linked to the very rare side effect while hundreds of others have also suffered illness as a result.

In what may be one of the biggest cases of its kind, more cases are expected to be lodged, meaning the vaccine manufacturer could face up to £80million in compensation payouts if it loses, according to The Telegraph.

The government indemnified AstraZeneca and other vaccine manufacturers as it sought to roll out vaccines during the pandemic.

Under Vaccine Damage Payment scheme, victims of certain vaccines, including ones used to beat Covid, are entitled to a one-off 'all-or-nothing' sum of £120,000 from the Government.

Tory MP Sir Jeremy Wright, whose constituent Jamie Scott suffered a 'significant permanent brain injury' from a blood clot after getting the job in 2021, has urged the government to take action.

The former Attorney General said: 'The public need the confidence to know they will be looked after if in the tiny, tiny minority of cases where the vaccine has gone wrong.

'And that confidence is damaged if the Government does not step in and settle these cases.'

The claimants are suing under the Consumer Protection Act, suggesting that the vaccine was not as safe as those who received it were led to believe.

AstraZeneca is fighting the claims, calling them 'confused' and 'wrong in law'.

The company has also pointed to the millions of lives the vaccine is believed to have saved in its first year of rollout.

The AstraZeneca vaccine is not being used as part of the UK's booster programme after experts recommended mRNA vaccines – such as the Pfizer or Moderna jabs – should be used instead.

Vaccine complications have been listed on the death certificates of a number of people who were administered the AstraZeneca jab.

Dr Stephen Wright, 32, died from a blood clot to the brain ten days after having his first dose of the AstraZeneca jab in January 2021.

In April last year, a coroner ruled the vaccine should be added to Dr Wright's death certificate.

In another case, a rock musician known as Lord Zion suffered a severe headache and was admitted to hospital eight days after receiving the jab.

His condition worsened and he passed away in hospital on May 19, with the preliminary death certificate listing a brain bleed caused by vaccine complications as the cause.

His partner Vikki said she is still 'pro-vaccine' following his death, but called on the Government to better educate medical staff on the side effects and rework the Vaccine Damage Payment Scheme.



Tuesday, February 06, 2024

COVID-19 Vaccination Rates Near Collapse in Europe--Market for mRNA Vaccines in Danger

The European Center for Disease Prevention and Control (ECDC) releases the COVID-19 vaccination coverage data for the 2023-24 season vaccination campaigns. The ECDC by September 2023, updated its COVID-19 vaccination coverage data analysis process. The latest data report is an interim description of COVID-19 vaccination in the European Union/European Economic Area (EU/EEA) between September 2023 and January 2024.

What becomes clear is much like in America, a precipitous drop in COVID-19 vaccination rates. In fact, TrialSite suggests a collapse in market demand, such a collapse that the vaccine makers will consider their options as time progresses to the next vaccination season.

A handful of countries on the continent report high rates (Denmark for example) but the overall rates have plummeted. A pattern emerges in that eastern nations in Europe have all but dropped the mRNA vaccine product. Moderna is locked out of the lucrative European market, and while Pfizer’s partnership with Germany’s BioNTech ensured it the overwhelming lead position, its COVID-19 vaccine and antiviral sales all but collapsed.

During the reporting period, 24/30 EU/EEA countries reported data on COVID-19 vaccination coverage for at least one target group (people aged 60 years and above, people aged 80 years and above, healthcare workers, individuals with chronic conditions, pregnant women). Approximately 19.4 million people during this period, aged 60 years and up received one COVID-19 vaccine dose.

At least 5.5 million people aged 80 years and above opted to receive the jab. The median COVID-19 vaccination coverage among the most high-risk cohorts in Europe—persons aged 60 years and above equaled 11.1% (range 0.01-65.8%). This specific median indicates the rates skewed to the lower end. The even more high-risk cohort of 80 years of age and up were vaccinated at 16.3% (0.01-88.2%) with high variation among countries, but clearly among the whole content much like in America the demand for COVID-19 vaccination all but collapsed.

Only a handful of nations’ populations went out in force to get the COVID-19 jab during the 2023-2024 season. Of the 24 European countries reporting, three countries reported a vaccination coverage of ≥50% for the age group 60 years and above, while eight countries reported a vaccination coverage of ≥50% for the age group 80 years and above.

What was the most used vaccine brand? The Pfizer-BioNTech product was originally developed by Germany’s BioNTech. A majority of the 22.7 million COVID-19 vaccine doses administered in the EU/EEA during this period in the overall population were the Comirnaty Omicron XBB.1.5 (Pfizer BioNTech) vaccine (around 22 million doses; 97% of the total doses administered). Moderna’s all but cut out of the European market which should have a profound impact on its vaccine sales forecasts.

The ECDC reminds all analysts that the preliminary results herein must be interpreted with caution. A higher degree of data consolidation and data completeness is expected in the coming weeks and months.


Australian Employer Ordered to Pay Compensation for Vaccine Injured in ‘Significant Precedent’

An Australian court has ordered an employer to pay weekly compensation and medical expenses to an employee after ruling that a vaccine injury that occurred from a workplace directive is compensable under the law.

Daniel Shepherd, 44, worked as a child and youth support worker with South Australia’s Department of Child Protection when he developed pericarditis after receiving his third Pfizer COVID-19 vaccine in February 2022.

Pericarditis is inflammation of the pericardium, a thin sac that surrounds the heart. The condition is reported to be more common in males aged 18 to 49, with an estimated 27 cases per 100,000 doses.

Mr. Shepherd was told by his employer that his employment would be terminated if he did not receive the third dose of the Pfizer COVID-19 vaccine. The directions for the mandate were made under Section 25 of South Australia’s Emergency Management Act in January 2022, which required support and healthcare workers to receive a third dose of the COVID-19 vaccine to continue working.

Mr. Shepherd received two COVID-19 vaccinations on Aug. 19, 2021, and Sept. 9, 2021, respectively, according to documents submitted to the South Australian Employment Tribunal.
On the first dose, Mr. Shepherd experienced aching joints, cold, and flu symptoms, and minor chest pain for one to two weeks. He experienced similar symptoms on his second dose.

Mr. Shepherd then received his third booster dose on Feb. 24, 2022, after receiving a message from his employer saying that employees needed to have a third dose of vaccine within four months of having a second vaccine.

The following day, Mr. Shepherd experienced severe chest pain, which worsened over the next two weeks.

On March 11, 2022, the chest pain was so unbearable that he felt “like someone was kneeling on his chest.” Having thought he was experiencing a heart attack, Mr. Shepherd was taken by ambulance to the Ashford Hospital, where cardiologists diagnosed him with pericarditis.

The 44-year-old husband and father of a 5-year-old boy noted some improvement four to five months after the chest pain; however, further episodes of severe chest pain followed and symptoms returned.

Mr. Shepherd has not worked since March 2022, except for two months when he worked part-time in an administrative role.

Vaccine-Injured Files Claim Against the State

Mr. Shepherd filed a claim for compensation against his employer, the State of South Australia, which was initially rejected.

The state had initially contested the connection between the vaccine and the injury but later acknowledged that the third dose caused Mr. Shepherd’s pericarditis and subsequent incapacity to work.

Despite that, the state argued that the injury didn’t arise from his employment under the Return to Work Act, and that the injury was linked to the Emergency Management Act.

The state argued that if criteria under the Return to Work Act are met, they are exempt from liability in relation to the broader management of the pandemic under the Emergency Management Act.

But Tribunal deputy president Judge Mark Calligeros rejected those arguments.

“The injury was a direct consequence of an Emergency Management Act vaccination direction and of Mr. Shepherd’s employment,” Judge Calligeros said.

“The connection between employment and the injury is a strong one, given I have found that Mr. Shepherd would not have had a third dose of the vaccine if he had not been required to in order to continue working.

“The state required Mr. Shepherd to be vaccinated to continue working in a healthcare setting because it sought to protect and reduce the risk of infection to the public and general and those members of the public receiving healthcare services in particular.

“It would be ironic and unjust if Mr. Shepherd was denied financial and medical support by complying with the state’s desire to preserve public health.

“The rejection of Mr. Shepherd’s claim should be set aside, and it should be ordered instead that he receive weekly payments of income support and payment of medical expenses.”
Ongoing Pain

Currently, Mr. Shepherd tires easily, and becomes tired after walking his son to school, some 400 metres (437 yards) from his home. Prior to the injury, he was able to hike up and down Mount Lofty, walk, and do Chinese boxing, which he is now unable to do.

In an interview with 9News, Mr. Shepherd said he now has the heart of a 90-year-old. “Even today with just mild exertion [I get] chest pains and then it’s followed by fatigue, like severe fatigue,” he said. “It’s heartbreaking to have to say, ‘Sorry buddy, daddy’s tired’.”

In a social media post, Senator Gerard Rennick said the ruling is a “significant precedent.”

“[E]mployers are now going to think twice about forcing people to get a vaccine if they have to fork out for potentially significant medical costs if the employee then incurs a vaccine injury,” Mr. Rennick said.

“This is only one case, and I suspect it will be appealed.

“I hope the decision is upheld because it will then open up the option of employers suing governments who mandate vaccines or pharmaceutical companies for unsafe or ineffective vaccines.”




Monday, February 05, 2024

mRNA COVID-19 Vaccines Caused More Deaths Than Saved: Study

With considerably lower efficacy rates, mRNA COVID-19 vaccines cause more deaths than save lives, according to a new study whose researchers called for a “global moratorium” on the shots and “immediate removal” from childhood immunization schedule.

The peer-reviewed study, published in the Cureus journal on Jan. 24, analyzed reports from the initial phase 3 trials of Pfizer and Moderna COVID-19 mRNA vaccines. These trials led to the shots being approved under Emergency Use Authorization (EUA) in the United States. The study also looked into several other research and reviews of the trials. It found that the vaccines had “dramatically lower” efficacy rates than the vaccine companies claimed.

Moreover, based on “conservative assumptions, the estimated harms of the COVID-19 mRNA vaccines greatly outweigh the rewards: for every life saved, there were nearly 14 times more deaths caused by the modified mRNA injections.”

“Given the well-documented SAEs (serious adverse events) and unacceptable harm-to-reward ratio, we urge governments to endorse and enforce a global moratorium on these modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.”

The authors also recommended an “immediate removal” of the COVID-19 vaccines from the childhood immunization schedule. They pointed out that children were at very low risk from the infection.

“It is unethical and unconscionable to administer an experimental vaccine to a child who has a near-zero risk of dying from COVID-19 but a well-established 2.2 percent risk of permanent heart damage based on the best prospective data available.”

Very Low Efficacy Rate

Following the first trials of Pfizer and Moderna, it was claimed that mRNA COVID-19 vaccines had a 95 percent reduction of symptomatic COVID-19. The study pointed out that this efficacy assumption was false

Pfizer’s claim was based on the fact that only eight out of 22,000 vaccine recipients contracted COVID-19 during the trial compared to 162 out of 22,000 people in the placebo group. In total, 170 confirmed COVID-19 cases were reported in both groups.

However, the researchers pointed out that a large number of infections fell under the “suspected” COVID-19 category, which was ignored. A total of 3,410 such suspected cases were identified in the trial, which is 20 times the 170 confirmed cases.

“There were 1,594 such cases in the vaccinated group and 1,816 in the placebo. When factoring in both confirmed and suspected cases, vaccine efficacy against developing symptoms drops to only 19 percent, far below the 50 percent RR (relative risk) reduction threshold required for regulatory authorization,” the study said.

“Thus, when considering both confirmed and suspected cases, vaccine efficacy appears to have been dramatically lower than the official 95 percent claim.”

The study’s authors declared no financial support from any organization for their work. A few conflict of interest disclosures were made.

One author received a grant from Quanta Computer Inc. Another author, cardiologist Peter A. McCullough, declared employment and owning stock/stock options in The Wellness Company. A third author is the founder of the Vaccine Safety Research Foundation (VSRF).

Lives Saved Versus Deaths

Researchers criticized the Pfizer and Moderna trial reports for “exclusive focus” on relative risk or RR measure while omitting absolute risk reduction. They argued that absolute risk reduction “gives a better indication of a drug’s clinical utility.”

“Both types of risk estimation are required to avoid reporting bias and to provide a more comprehensive perspective on vaccine efficacy. Omitting the absolute risk statistics leads to overestimation of the clinical benefits of the vaccines.”

In contrast with the 95 percent efficacy rate using the RR measure, absolute risk reduction for Pfizer and Moderna vaccines were 0.7 percent and 1.1 percent, respectively, the study stated.

“An absolute risk reduction of approximately 1 percent for the COVID-19 mRNA vaccinations meant that a substantial number of individuals would need to be injected in order to prevent a single mild-to-moderate case of COVID-19.”

To prevent one case of COVID-19 infection, 142 individuals would need to be vaccinated with Pfizer’s shot, the study said. When it came to Moderna, 88 people had to be injected.

Taking into account these numbers as well as the infection fatality rates of COVID-19, the researchers concluded that roughly 52,000 people would need to be vaccinated to prevent one COVID-19-related death.

This would mean two lives saved for roughly 100,000 injections of the Pfizer vaccine. However, there is a risk of 27 deaths per 100,000 doses of Pfizer shot, the researchers calculated. As such, for every life saved by the jab, almost 14 lives would be lost due to the mRNA vaccine, the study stated.

Authors noted that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) “did not include absolute risk reduction measures” when reviewing vaccine data.

This action deviated from FDA guidelines “which state that both approaches are crucial in order to avoid the misguided use of pharmaceuticals.”

Serious Adverse Events

Researchers cited a September 2022 analysis to detail the pervasiveness of serious adverse effects (SAE) among the vaccinated group in the trials. The analysis looked at both Pfizer and Moderna trial data, discovering roughly 125 SAEs per 100,000 vaccine recipients. This indicated one SAE per 800 vaccines.

“The Pfizer trial exhibited a 36 percent higher risk of serious adverse events in the vaccine group (compared to placebo) … The Moderna trial exhibited a 6 percent higher risk of serious adverse events in the vaccine group,” the analysis stated.

“These findings stand in sharp contrast with the FDA’s initial claim that SAEs reported by the two pivotal trials were ‘balanced between treatment groups,’” researchers from the Jan. 24 study noted.

This discrepancy could be because the FDA only counted the number of individuals with serious adverse events rather than the total SAEs experienced by the trial subjects, they said.

Since a single person can have multiple SAEs, counting only individuals would produce a lower number than the total number of such adverse events.

“When the SAEs were viewed collectively, the risks in the vaccine group were substantially elevated beyond those previously determined by the FDA,” the researchers wrote.

The analysis found that the excess risk of serious adverse events of special interest (AESI) among the placebo group was 10.1 per 10,000 individuals. However, the risk reduction for COVID-19 hospitalization in this group was only 2.3 per 10,000 people.

This meant that the subjects were at over four times the risk of suffering AESIs after getting vaccinated than they were of getting hospitalized from the infection. In the Moderna trial, subjects were more than two times at risk of experiencing AESI than being hospitalized.

“To put these findings in perspective, the official SAE rate for other vaccines is only 1-2 per million,” the Jan. 24 study said. The 2020 analysis’ “estimate based on the Pfizer trial data (1,250 SAEs per million) exceeds this benchmark by at least 600-fold.”

Rushed Vaccines

In the Jan. 24 study, researchers noted that the safety of mRNA products was “never assessed” in a manner consistent with scientific standards for vaccines or for gene therapy products (GPT), which they claim is “the more accurate classification” for these jabs. “Many key trial findings were either misreported or omitted entirely from published reports.”

The usual safety testing protocols and toxicology requirements were bypassed by the FDA and vaccine manufacturers. As the two trials were terminated prematurely, there was never an “unbiased assessment” of potential serious adverse events.

“It was only after the EUA that the serious biological consequences of rushing the trials became evident, with numerous cardiovascular, neurological, reproductive, hematological, malignant, and autoimmune SAEs identified and published in the peer-reviewed medical literature.”

In addition, the COVID-19 mRNA vaccines produced and evaluated in the trials were not the same ones that were manufactured and administered to people around the world. The global vaccination campaign used a vaccine produced by a different process, which has been shown to have “varying degrees of DNA contamination.”

The researchers pointed out that several excess deaths, cardiac events, strokes, and other serious adverse events have wrongly been ascribed to COVID-19 rather than the COVID-19 mRNA vaccines since early 2021.

Injuries from these vaccines overlap with both post-acute COVID-19 syndrome (PACS) and severe acute COVID-19 illness, which end up often obscuring the vaccine’s contribution to such conditions. “Multiple booster injections appear to cause immune dysfunction, thereby paradoxically contributing to heightened susceptibility to COVID-19 infections with successive doses.”

For the “vast majority” of adults below 50 years of age, the perceived benefits of the mRNA vaccines were dwarfed by their “potential disabling and life-threatening harm.” The study said older adults may be at higher risk of such harm.

CDC and FDA Criticized

Commenting on the study, Mat Staver, the founder and chairman of nonprofit Liberty Counsel, said that in the paper, scientists “confirm what sound scientific research has been showing for years, that these shots have never been safe nor effective.”

“The FDA and the CDC are supposed to protect the people, but they have become the lapdog of the pharmaceutical industry. This must change.”

The CDC is currently under scrutiny for suppressing an alert for myocarditis from COVID-19 vaccination. Myocarditis is an inflammation of the heart muscle called the myocardium.

A document recently obtained by The Epoch Times shows that in May 2021, the CDC had prepared a draft alert for myocarditis related to the jabs.

The agency was supposed to send the alert to federal, state, and local public health officials and doctors nationwide through its Health Alert Network (HAN). However, the alert was never sent as some officials were worried about appearing “alarmist.”